Target intelligence / Profile preview

Oxalate metabolism enzymes of Lactobacillus acidophilus LA14 (OXC/FRC system)

Target
OXC/FRC system
Molecular classification
Enzyme, Lyase, Transferase
01

Overview

Lactobacillus acidophilus LA14 is a probiotic bacterium that expresses a specific set of enzymes dedicated to the degradation of oxalate, a common dicarboxylic acid found in leafy greens, nuts, and seeds. The primary components of this metabolic pathway are oxalyl-CoA decarboxylase (OXC) and formyl-CoA transferase (FRC), which work together to convert oxalate into formate and carbon dioxide within the gut lumen. By actively catabolizing oxalate before it can be absorbed into the bloodstream, these enzymes play a critical role in reducing the systemic burden of oxalate. This activity is particularly relevant for the prevention of calcium oxalate kidney stones, which form when high levels of oxalate are excreted by the kidneys. Therapeutic applications focus on using LA14 as a biotherapeutic agent to restore oxalate-degrading capacity in the gut microbiota of patients with hyperoxaluria or those at high risk for recurrent urolithiasis.

Other names
Oxalate-degrading enzymesOxalyl-CoA decarboxylase (OXC)Formyl-CoA transferase (FRC)Oxalate catabolic pathway
02

Mechanism of action

The enzymes facilitate the breakdown of dietary oxalate in the gastrointestinal tract. Formyl-CoA transferase (FRC) activates oxalate to oxalyl-CoA, which is then decarboxylated by oxalyl-CoA decarboxylase (OXC) into formate and carbon dioxide, thereby reducing the intestinal absorption of oxalate and its subsequent excretion in the urine.

03

Biological functions

Oxalate catabolismMetabolic processIntestinal detoxification
04

Disease associations

HyperoxaluriaUrolithiasis (Kidney stones)Enteric hyperoxaluria
05

Safety considerations

Risk of bacteremia in severely immunocompromised patientsPotential for antibiotic interference with probiotic viabilityStrain-specific efficacy variations
06

Interacting drugs

Lactobacillus acidophilus LA14 (Probiotic)

1 more in the full profile.

07

Biomarkers

Urinary oxalate levelsFecal L. acidophilus LA14 concentrationPlasma oxalate concentration

Beyond the preview

Go deeper on Oxalate metabolism enzymes of Lactobacillus acidophilus LA14 (OXC/FRC system).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxalate metabolism enzymes of Lactobacillus acidophilus LA14 (OXC/FRC system).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call